Construction and functional characterization of mutants of the bovine leukaemia virus trans-activator protein p34tax

References

1. Burny A., Bruck C., Chantrenne H., Cleuter Y., Dekegel D., Ghysdael J., Kettmann R., Leclercq M., Leunen J., Mammerickx M., Portetelle D. 1980; Bovine leukemia virus: molecular biology and epidemiology. In Viral Oncology pp 231–289 Edited by Klein G. New York: Raven Press;
   [Google Scholar]
2. Derse D. 1987; Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements. Journal of Virology 61:2462–2471
   [Google Scholar]
3. Friedman A. D., Triezenberg S. J., McKnight S. L. 1988; Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus. Nature, London 335:452–454
   [Google Scholar]
4. Gorman C. M., Merlino G. T., Willingham M. C., Pastan I., Howard B. H. 1982a; The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proceedings of the National Academy of Sciences, U.S.A 79:6777–6781
   [Google Scholar]
5. Gorman C. M., Moffat L. F., Howard B. H. 1982b; Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Molecular and Cellular Biology 2:1044–1051
   [Google Scholar]
6. Green M., Ishino M., Loewenstein P. M. 1989; Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression. Cell 58:215–223
   [Google Scholar]
7. Inoue J., Seiki M., Yoshida M. 1986; The second pX product p27^X-III of HTLV-I is required for gag gene expression. FEBS Letters 209:187–190
   [Google Scholar]
8. Itohara S., Sekikawa K. 1987; Molecular cloning of infectious proviral genomes of bovine leukemia virus. Virology 159:158–160
   [Google Scholar]
9. Itohara S., Tomiyama T., Ushimi C., Sekikawa K. 1988; Cooperative regulation of bovine leukaemia virus gene expression by two overlapping open reading frames in the XBL region. Journal of General Virology 69:797–804
   [Google Scholar]
10. Katoh I., Yoshikawa Y., Ikawa Y. 1989; Bovine leukemia virus trans-activator p38^tax activates heterologous promoters with a common sequence known as a cAMP-responsive element or the binding site of a cellular transcription factor ATF. EMBO Journal 8:497–503
    [Google Scholar]
11. Rice N. R., Simek S. L., Dubois G. C., Showalter S. D., Gilden R. V., Stephens R. M. 1987; Expression of the bovine leukemia virus X region in virus-infected cells. Journal of Virology 61:1577–1585
    [Google Scholar]
12. Rimsky L., Duc Dodon M., Dixon E. P., Greene W. C. 1989; Trans-dominant inactivation of HTLV-I and HIV-1 gene expression by mutation of the HTLV-I Rex transactivator. Nature, Ixmdon 341:453–456
    [Google Scholar]
13. Rosen C. A., Sodroski J. G., Willems L., Kettmann R., Campbell K., Zaya R., Burny A., Haseltine W. A. 1986; The 3′ region of bovine leukemia virus genome encodes a trans–activator protein. EMBO Journal 5:2585–2589
    [Google Scholar]
14. Sagata N., Tsuzuku-Kawamura J., Nagayoshi-Aida M., Shimizu F., Imagawa K., Ikawa Y. 1985a; Identification and some biochemical properties of the major X_BL gene product of bovine leukemia virus. Proceedings of the National Academy of Sciences, U.S.A 82:7879–7883
    [Google Scholar]
15. Sagata N., Yasunaga T., Tsuzuku-Kawamura J., Ohishi K., Ogawa Y., Ikawa Y. 1985b; Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses. Proceedings of the National Academy of Sciences, U.S.A 82:677–681
    [Google Scholar]
16. Sakurai M., Strominger J. L. 1988; B-cell-specific enhancer activity of conserved upstream elements of the class II major histocompatibility complex DQB gene. Proceedings of the National Academy of Sciences, U.S.A 85:6909–6913
    [Google Scholar]
17. Shima H., Takano M., Shimotohno K., Miwa M. 1986; Identification of p26^Xb and p24^Xb of human T-cell leukemia virus type II. FEBS Letters 209:289–294
    [Google Scholar]
18. Slamon D. J., Shimotohno K., Cline M. J., Golde D. W., Chen I. S. Y. 1984; Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-I and HTLV-II. Science 226:61–65
    [Google Scholar]
19. Smith M. R., Greene W. C. 1990; Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes and Development 4:1875–1885
    [Google Scholar]
20. Wachsman W., Cann A. J., Williams J. L., Slamon D. J., Souza L., Shah N. P., Chen I. S. Y. 1987; HTLV x gene mutants exhibit novel transcriptional regulatory phenotypes. Science 235:674–677
    [Google Scholar]
21. Willems L., Chen G., Portetelle D., Mamoun R., Burny A., Kettmann R. 1989; Structural and functional characterization of mutants of the bovine leukemia virus transactivator protein p34. Virology 171:615–618
    [Google Scholar]
22. Willems L., Heremans H., Chen G., Portetelle D., Billiau A., Burny A., Kettmann R. 1990; Cooperation between bovine leukemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO Journal 9:1577–1581
    [Google Scholar]